DNMTs targeting by genetic ablation or pharmacological inhibition decreased fibrosis and prevented the AKI-to-CKD transition in part because of preserved expression of Klotho and RASAL1 (Bechtel et al., 2010; Sun et al., 2012; Tampe et al., 2017). This evidence concerns the gene RASAL1 and acute kidney injury.